Compare ENTA & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTA | FET |
|---|---|---|
| Founded | 1995 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.3M | 514.7M |
| IPO Year | 2013 | 2012 |
| Metric | ENTA | FET |
|---|---|---|
| Price | $14.04 | $47.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.40 | N/A |
| AVG Volume (30 Days) | 220.0K | ★ 230.9K |
| Earning Date | 02-09-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $66,980,000.00 | ★ $790,292,000.00 |
| Revenue This Year | $0.99 | N/A |
| Revenue Next Year | $0.19 | $2.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.58 | N/A |
| 52 Week Low | $4.09 | $12.78 |
| 52 Week High | $17.15 | $49.72 |
| Indicator | ENTA | FET |
|---|---|---|
| Relative Strength Index (RSI) | 55.34 | 63.05 |
| Support Level | $13.18 | $46.19 |
| Resistance Level | $15.55 | $49.13 |
| Average True Range (ATR) | 0.66 | 2.21 |
| MACD | 0.17 | 0.02 |
| Stochastic Oscillator | 50.00 | 66.87 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.